Message-ID: <9972489.1075845379243.JavaMail.evans@thyme>
Date: Mon, 4 Jun 2001 21:07:05 -0700 (PDT)
From: 1.10043390.-2@multexinvestornetwork.com
To: jwillia@enron.com
Subject: June 5, 2001 - Mergers, biotech and fuel-cell tech
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-From: Multex Investor <1.10043390.-2@multexinvestornetwork.com>@ENRON <IMCEANOTES-Multex+20Investor+20+3C1+2E10043390+2E-2+40multexinvestornetwork+2Ecom+3E+40ENRON@ENRON.com>
X-To: jwillia@enron.com
X-cc: 
X-bcc: 
X-Folder: \Williams, Jason (Trading)\Williams, Jason (Trading)\Inbox
X-Origin: WILLIAMS-J
X-FileName: Williams, Jason (Trading).pst

In today's Daily Update, you'll find forward-looking research on
Celera Genomics (CRA), Arena Pharmaceuticals (ARNA), Diversa (DVSA),
Genome Therapeutics (GENE), Lynx Therapeutics (LYNX), Maxygen (MAXY)
Ballard Power Systems (BLDP), FuelCell Energy (FCEL), H Power (HPOW),
Hydrogenics (HYGS), United Technologies (UTX), Plug Power (PLUG) and
much more.

For free research, editor's picks, and more come to the Daily Investor:
http://www.multexinvestor.com/magazinecover.asp?nd=0605#investor
***************************************************************
You are receiving this mail because you have registered for
Multex Investor. To unsubscribe, see bottom of this message.
***************************************************************

======================== Sponsored by =========================
Save your investing year!  Profit from the inevitable monster
Nasdaq comeback rally.  ChangeWave has identified five NextGen
leaders set to blow the lid off analysts estimates as the economy
begins to recover NEXT quarter.  Discover these five "first-movers"
In FREE special report "Profiting from the Tech Comeback" at:

http://www.changewave.com/b/6/mltx1/
===============================================================

Featured in today's edition of the Daily Update:

1. TODAY'S SPECIAL REPORT: Jefferies & Co. examines enterprise software's
mass-market appeal and its challenges.

2. DAILY FREE SPONSOR REPORT: Morgan Stanley reiterates its rating on JDS
Uniphase (JDSU).

3. FREE RESEARCH REPORT: Lehman Bros. projects there'll be more
outperforming stocks among the cyclicals in its European "Recommended
Portfolio."

4. ASK THE ANALYST: Market Edge's Tom Ventresca explains why his
proprietary technical models are predicting a mixed market.

5. INDEPENDENT'S INVESTMENT REVIEW: The451 explains why after the tech
boom, business-process outsourcing is corporate America's salvation.

6. WORD FROM OUR SPONSOR: American Century: International Investing

7. HOT REPORT: Jefferies & Co. provides an update on the industry and the
public and private companies driving innovations.

8. INVESTORS' CHOICE: 3-DAY FAVORITE: Argus Research's team comments on
the economy's outlook and the Fed's next moves, as well their impact on
stocks.

9. EDITOR'S PICK: Friedman, Billings, Ramsey & Co. asks, "What is fair to
expect of genomics, now and later?"

10. MESSAGE BOARDS: Looking for intelligent conversation? Stocks, funds,
finance and hot topics are among the Sage possibilities.

======================== Sponsored by =========================
A special offer from Merrill Lynch Direct!

Self-directed investors can access Merrill Lynch's research and
market information and trade online from $29.95 per equity trade.
Open an account and get $100.  Click here to learn more.

http://www.mldirect.ml.com/publish/public/offer.asp?medium=MUL0002&
===============================================================

1. TODAY'S SPECIAL REPORT
The ideal environment for M&A -- Jefferies & Co. examines enterprise
software's mass-market appeal and its challenges.

The migration of e-business onto the Internet is being driven by
functionality and economies of scale the firm claims as it projects the
pace of "the mating dance" to speed up. Which are the likely candidates?
(20-page report for purchase - $50).
Click here.
http://www.multexinvestor.com/download.asp?docid=20677910&nd=0605


2. DAILY FREE SPONSOR REPORT
JDS Uniphase (JDSU) -- Morgan Stanley Stanley reiterates its rating on the
optical component manufacturer.

"We recognize that JDSU shares already reflect much of the industry's
recent deceleration, but believe that four factors are not priced into the
stock," the firm says and names those factors. Sign up for the firm's
free-research trial to access the report.
Click here.
http://www.multexinvestor.com/download.asp?docid=4475777&sid=8&nd=0605


3. FREE RESEARCH REPORT
Portfolio catch up in European stocks -- Lehman Bros. projects there'll be
more outperforming stocks among the cyclicals in its "Recommended
Portfolio."

The firm explains that it "isolates those stocks that still look
attractively valued but have (yet) responded," and replaces Peugeot,
Electrolux, BASF, and NH Hoteles with four other "value" stocks. This
report remains free for a limited time.
Click here.
http://www.multexinvestor.com/magazinecover.asp?nd=0605#investor


4. TODAY IN THE ANALYST CORNER
Market review and forecast for June 2001 -- Market Edge's Tom Ventresca is
expecting a mixed market through early July.

Ventresca's technical models are predicting a short-term neutral
environment for stocks. Where does he see support and resistance? He will
be in the Analyst Corner only until 5 p.m. ET Tues., June 5, so be sure to
ask your question now. Ask the analyst.
Click here.
http://www.multexinvestor.com/ACHome.asp?nd=0605

Get a "Second Opinion" before you make your next investment decision.
Free offer from Market Edge.
Click here.
https://www.marketedge.com/Secure/Subscrib/MultexIntro.asp?Location=3


5. INDEPENDENT'S INVESTMENT REVIEW
Business-process outsourcing (BPO) -- The451 explains why after the tech
boom, BPO is corporate America's salvation.

After network, infrastructure, e-business and offshore, BPO is reportedly
the fastest-growing outsourcing market in information tech. The research
names some heavy hitters and the industries likely to need them (2-page
report for purchase - $5).
Click here.
http://www.multexinvestor.com/download.asp?docid=20776788&nd=0605

======================== Sponsored by =========================
Win $25,000 in the Multex Investor Challenge -- Round 2

It's like a flight simulator for investors. The Multex Investor
Challenge let's you manage a $100,000 virtual portfolio risk-free
with a chance to win $25,000 and other GREAT prizes.

http://www2.investmentchallenge.com/multex?promo=unl
===============================================================

6. WORD FROM OUR SPONSOR
American Century: International Investing

The thoughtful selection of international funds may help you diversify
your investments and take advantage of growth available from markets
around the world.
Click here.
http://www.americancentury.com/mi/article23.html?nd=0605


7. WHAT'S HOT?
Fuel-cell technology -- Jefferies & Co. provides an update on the
industry, and the public and private companies driving innovations.

Everything you want to know about fuel cell tech and the companies behind
it: Ballard Power Systems (BLDP), FuelCell Energy (FCEL), H Power (HPOW),
Hydrogenics (HYGS), United Technologies (UTX), Plug Power (PLUG) (9-page
report for purchase - $25).
Click here.
http://www.multexinvestor.com/download.asp?docid=20697260&nd=0605


8. INVESTORS' CHOICE: 3-DAY FAVORITE
Responding to the U.S. growth recession -- Argus Research's team comments
on the economy's outlook and its impact on select stocks.

The report's authors pick Cisco (CSCO) as the "focus stock," evaluate 11
growth stocks, 10 value stocks and 6 utility stocks, and comment on the
firm's latest ratings changes (40-page report for purchase - $10).
Click here.
http://www.multexinvestor.com/download.asp?docid=20689879&nd=0605


9. EDITOR'S PICK: CURRENT RESEARCH FROM THE CUTTING EDGE
Biotech: the significance of the genome -- Friedman, Billings, Ramsey &
Co. asks, "What is fair to expect of genomics, now and later?"

This comprehensive report also scrutinizes the following stocks: Celera
Genomics (CRA), Arena Pharmaceuticals (ARNA), Diversa (DVSA), Genome
Therapeutics (GENE), Lynx Therapeutics (LYNX), and Maxygen (MAXY)
(127-page report for purchase - $300).
Click here.
http://www.multexinvestor.com/download.asp?docid=20641575&nd=0605


10. MESSAGE BOARDS
Catch the buzz on the boards at Sage Online

If you're looking for lively, intelligent conversation, look no further.
Stocks and funds A to Z, finance and hot topics are only a few of the Sage
possibilities.
Click here.
http://multexinvestor.sageonline.com/page.asp?id=2904&ps=1&s=3&nd=0605

===================================================================
Please send your questions and comments to:
mailto:investor.help@multex.com

If you'd like to learn more about Multex Investor, please visit:
http://www.multexinvestor.com/welcome.asp

If you can't remember your password and/or your user name, click here:
http://www.multexinvestor.com/lostinfo.asp

If you want to update your email address, please click on the url below:
http://www.multexinvestor.com/edituinfo.asp
===================================================================
To remove yourself from the mailing list for the Daily Update, please
REPLY to THIS email message with the word UNSUBSCRIBE in the subject
line. To remove yourself from all Multex Investor mailings, including
the Daily Update and The Internet Analyst, please respond with the
words NO EMAIL in the subject line.

You may also unsubscribe on the account update page at:
http://www.multexinvestor.com/edituinfo.asp

===================================================================
Please email advertising inquiries to us at:
mailto:advertise@multex.com.

For information on becoming an affiliate click here:
http://www.multexinvestor.com/Affiliates/home.asp

Be sure to check out our other newsletters, The Internet Analyst
and The Telecomm Analyst by Multex.com. The newsletters will
inform, educate, and entertain you with usable investment data,
ideas, experts, and info about the Internet and Telecommunications
sectors. To see this week's issue,
click here:
http://www.theinternetanalyst.com or
http://www.thetelecommanalyst.com